-
Munich Re actuary urges careful forethought on what gives a product 'ESG' credentials
11 July 2023Frank Schiller cautions actuaries, credibility may not always rest on investment reserves
-
DAV's Schiller puzzled by some EC proposals in Solvency II review
18 November 2021German actuaries tell David Walker of potential dissonance in different pronouncements that the EC has made about insurers' capital, including for 'green' investments, in its reform proposals for Solvency II
-
When actuarial science gets political
10 June 2021German insurers warn EU policy makers not to try and fix what is not broken in Solvency II, they also advise against politicising the rules which would lead to a skewed version of risk. David Walker reports
-
COMMENT: The rumble in the Solvency II jungle
14 May 2021BaFin and the European Commission go 'head to head', very politely
-
EC's head of Solvency II review warns: do not expect lower charges for green assets
13 May 2021German Association of Actuaries argues for 'same risk, same capital'
-
No yield, too few bunds - what investment trials mean for 2020 Review
03 April 2020Frank Schiller, board member of the DAV, tells David Walker in a far ranging interview his thoughts on the 2020 Solvency II review and where he believes EIOPA needs to step up its work.